A Study of AZD1222, a Vaccine for the Prevention of COVID-19 in Immunocompromised Adults

Clinical trial NCT05057897 · TERMINATED

Trial details

NCT number: NCT05057897
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

COVID-19, SARS-CoV-2

Start date: 2022-01-31
Primary completion: 2023-04-19
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.